Skip to main content
Skip to main content
Back to Grand Rounds
Grand RoundsWeekly Evidence Brief

Family Medicine

Edition

30-Second Takeaway

  • Family interventions for adults with bipolar disorder reduce relapse, hospitalization, and improve adherence.

Week ending June 20, 2026

Family engagement, trial design, and appraisal innovations with direct clinical relevance

Family interventions reduce relapse and hospitalization in adult bipolar disorder

BIPOLAR DISORDERSJun 18, 2026

Systematic review of family interventions (adults with bipolar disorder and relatives) found reduced relapse and hospitalization across studies. Psychoeducational family interventions improved symptom severity and medication adherence. Benefits included better family communication, but long-term sustainability and generalizability were mixed.

Basket and umbrella trials may speed pediatric precision-drug testing

BMC MEDICAL RESEARCH METHODOLOGYJun 18, 2026

Systematic review found basket designs more common than umbrella trials in pediatric oncology and rare diseases. These designs can increase trial efficiency and enable biomarker-targeted conclusions when sample sizes are small. Successful use requires robust statistical planning, appropriate Bayesian methods, and regulatory alignment.

Older adults and families can help prevent medication errors during care transitions

JOURNAL OF CLINICAL NURSINGJun 20, 2026

Qualitative interviews (patients ≥65, family, clinicians; n=202) identified communication barriers and enablers for medication management across transitions. Participants proposed strategies to empower engagement that may reduce medication errors and adverse events. Implementing clearer communication tools and facilitating family involvement could improve transitional medication safety.

References

Numbered in order of appearance. Click any reference to view details.

Additional Reads

Optional additional studies from this edition.

Edition context

Clinical signal

  • Engage family members in bipolar care using psychoeducation when possible.
  • Interpret umbrella-review appraisals with caution; look for transparent methodological reconciliation.
  • Support older patients and families to participate in medication reconciliation during transitions.